Articles de revues sur le sujet « Hypercholesteremia »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Hypercholesteremia ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Visavadiya, Nishant P., and A. V. R. L. Narasimhacharya. "AsparagusRoot Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats." Evidence-Based Complementary and Alternative Medicine 6, no. 2 (2009): 219–26. http://dx.doi.org/10.1093/ecam/nem091.
Texte intégralKhan, Safi U., and Khurram Nasir. "Hypercholesteremia in Indigenous Population." JACC: Advances 2, no. 3 (2023): 100352. http://dx.doi.org/10.1016/j.jacadv.2023.100352.
Texte intégralNordin, Jenizan, and Ahmad Badruddin Ghazali. "Osteonecrosis of the jaw in patients taking Atorvastatin: Case series." IIUM Journal of Orofacial and Health Sciences 3, no. 2 (2022): 219–22. http://dx.doi.org/10.31436/ijohs.v3i2.73.
Texte intégralKamalova, Aelita A. "Diet Therapy in Children with Hypercholesteremia." Current Pediatrics 19, no. 4 (2020): 309–15. http://dx.doi.org/10.15690/vsp.v19i4.2140.
Texte intégralDietrich, Hans H. "Apolipoprotein E in Hypercholesteremia and Beyond." Stroke 38, no. 7 (2007): 2036. http://dx.doi.org/10.1161/strokeaha.107.489856.
Texte intégralLEWIS, S. "P514 Hypercholesteremia induces baroreceptro reflex dysfunction." European Heart Journal 24, no. 5 (2003): 81. http://dx.doi.org/10.1016/s0195-668x(03)93952-2.
Texte intégralNAKAI, TSUGUHIKO. "Familial hypercholesteremia complicated by nephrotic syndrome." Nihon Naika Gakkai Zasshi 79, no. 8 (1990): 1079–80. http://dx.doi.org/10.2169/naika.79.1079.
Texte intégralHURLEY, D. "Hypercholesteremia induces enhanced circulating inflammatory activity." American Journal of Hypertension 17, no. 5 (2004): S242. http://dx.doi.org/10.1016/j.amjhyper.2004.03.648.
Texte intégralLi, Nan F., Hong M. Wang, Jin Yang, Ling Zhou, Xiao G. Yao, and Jing Hong. "Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population." Applied Physiology, Nutrition, and Metabolism 34, no. 6 (2009): 1032–39. http://dx.doi.org/10.1139/h09-101.
Texte intégralKawsar, Dr Syeda Masuma, and Dr Amirul Islam Bhuyan. "Outcome of Heart Rate and Blood Pressure of a Patient after Successful Coronary Angioplasty and Stenting." Scholars Journal of Applied Medical Sciences 11, no. 03 (2022): 668–71. http://dx.doi.org/10.36347/sjams.2023.v11i03.031.
Texte intégralAlsaidan, Aseel Awad. "Knowledge, attitude, and practice of physicians towards familial hypercholesterolemia in north regions of Saudi Arabia." Journal of the Pakistan Medical Association 74, no. 2 (2024): 327–34. http://dx.doi.org/10.47391/jpma.9436.
Texte intégralNichols, E. H., and M. R. Jaff. "Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD." MD Conference Express 13, no. 19 (2013): 31. http://dx.doi.org/10.1177/155989771319015.
Texte intégralKumawat, Vinod Bihari, Surendra Kumar Sharma, Uttam Kumar Sharma, and Sudhir Sharma. "Effect of trikatu compound in hypercholesteremia- a clinical study." Environment Conservation Journal 16, no. 1&2 (2015): 57–61. http://dx.doi.org/10.36953/ecj.2015.161209.
Texte intégralTokura, T. "Changes in Bruch's Membrane in Experimental Hypercholesteremia in Rats." Japanese Journal of Ophthalmology 43, no. 4 (1999): 337–38. http://dx.doi.org/10.1016/s0021-5155(99)00055-6.
Texte intégralBARTON, M. "Hypercholesteremia induces cardiac concentric remodeling in the guinea pig." American Journal of Hypertension 17, no. 5 (2004): S165—S166. http://dx.doi.org/10.1016/j.amjhyper.2004.03.434.
Texte intégralYu, Lianlong, Qianrang Zhu, Yuqian Li, Pengkun Song, and Jian Zhang. "Dietary Branched-Chain Amino Acids (BCAAs) and Risk of Dyslipidemia in a Chinese Population." Nutrients 14, no. 9 (2022): 1824. http://dx.doi.org/10.3390/nu14091824.
Texte intégralRafaish, Hadeel Ganai, Wefak Albazi, Muna Hussain Al-Aameli, Tahreer M. Al-Thuwaini, and Goosoon Hadi Jhoni. "The effect of an induced hypercholesteremia on the regulation of the ARC gene expression, Brain Derived Neurotropic Factor (BDNF), Synapsing-1 and neurotransmitter –glutamate in male rats." Journal of Kerbala for Agricultural Sciences 11, no. 2 (2024): 11–29. http://dx.doi.org/10.59658/jkas.v11i2.1842.
Texte intégralElbadawi, Ayman, Islam Y. Elgendy, Mohamed Omer, et al. "Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia." American Journal of Medicine 134, no. 8 (2021): 992–1001. http://dx.doi.org/10.1016/j.amjmed.2021.03.013.
Texte intégralMalone, R., P. O'Connor, M. Hennessy, V. Crowley, and C. Kennedy. "Cardiovascular disease risk modifiers in patients with heterozygous familial hypercholesteremia." Atherosclerosis 379 (August 2023): S119. http://dx.doi.org/10.1016/j.atherosclerosis.2023.06.416.
Texte intégralAbumoawad, Abdelrhman, Hesham Mohamed A. Afify, Mohammed Saleh, et al. "OUTCOMES OF ACUTE ISCHEMIC STROKE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEREMIA." Journal of the American College of Cardiology 81, no. 8 (2023): 1879. http://dx.doi.org/10.1016/s0735-1097(23)02323-9.
Texte intégralHussain, Cheragh, Muhammad Asghar Khan, Yasir hayat, Nasir --, and Mahmood ul Hassan. "Frequency Of Hypercholesteremia In Patients Presenting With Acute Coronary Syndrome." Global Pharmaceutical Sciences Review VIII, no. I (2023): 71–77. http://dx.doi.org/10.31703/gpsr.2023(viii-i).11.
Texte intégralNagaraj, Lavanya, and Naveen Kumar Madalageri. "A comparative study of metabolic side effects of risperidone and olanzapine in the treatment of schizophrenia." International Journal of Basic & Clinical Pharmacology 8, no. 11 (2019): 2561. http://dx.doi.org/10.18203/2319-2003.ijbcp20194803.
Texte intégralKoo, Hui Chin, Lay Kim Tan, Geok Pei Lim, Chee Cheong Kee, and Mohd Azahadi Omar. "Obesity and Its Association with Undiagnosed Diabetes Mellitus, High Blood Pressure and Hypercholesterolemia in the Malaysian Adult Population: A National Cross-Sectional Study Using NHMS Data." International Journal of Environmental Research and Public Health 20, no. 4 (2023): 3058. http://dx.doi.org/10.3390/ijerph20043058.
Texte intégralAdama, D., NE Yisa, S. Adama, et al. "Cardiometabolic Risk Screening of Students Attending School of Health Technology, Minna, Niger State, Nigeria." Journal of Medical Laboratory Science 31, no. 2 (2021): 42–51. https://doi.org/10.5281/zenodo.5033240.
Texte intégralDidia, S. Claudia. "PCSK9-Inhibitors: A Review of a Novel Approach in Hypercholesteremia Management." Medical Science Review 1 (2014): 1–6. http://dx.doi.org/10.12659/msrev.890836.
Texte intégralSaotome, Masao, and Yuichiro Maekawa. "A Japanese Woman with Polygenic Familial Hypercholesteremia Who Exhibited Trivial Atherosclerosis." Internal Medicine 63, no. 15 (2024): 2111–12. http://dx.doi.org/10.2169/internalmedicine.3089-23.
Texte intégralVerma, Isha, Antonio Fernandez, and Paul Thompson. "FAMILIAL HYPERCHOLESTEREMIA: WHEN STATINS, EZETIMIBE & PCSK9 INHIBITORS ARE NOT ENOUGH." Journal of the American College of Cardiology 71, no. 11 (2018): A2439. http://dx.doi.org/10.1016/s0735-1097(18)32980-2.
Texte intégralVerma, Isha, Paul D. Thompson, and Antonio B. Fernandez. "Familial Hypercholesteremia: When Statins, Ezetimibe & PCSK9 Inhibitors Are Not Enough." Journal of Clinical Lipidology 12, no. 2 (2018): 545. http://dx.doi.org/10.1016/j.jacl.2018.03.043.
Texte intégralValentine, V. G., L. Seoane, D. M. Fuchs, S. G. LaPlace, G. A. Lombard, and D. E. Taylor. "Potential benefits of treating hypercholesteremia and hypertension in lung allograft recipients." Journal of Heart and Lung Transplantation 24, no. 2 (2005): S170. http://dx.doi.org/10.1016/j.healun.2004.12.105.
Texte intégralMUNDAY, J. "Hypercholesteremia-induced changes in left ventricular geometry in the guinea pig." American Journal of Hypertension 17, no. 5 (2004): S168. http://dx.doi.org/10.1016/j.amjhyper.2004.03.441.
Texte intégralFan, Jing, Caicui Ding, Weiyan Gong, et al. "The Relationship between Leisure-Time Sedentary Behaviors and Metabolic Risks in Middle-Aged Chinese Women." International Journal of Environmental Research and Public Health 17, no. 19 (2020): 7171. http://dx.doi.org/10.3390/ijerph17197171.
Texte intégralZhang, Haoqiang, Rong Huang, Sai Tian, et al. "The CC Genotype of Insulin-Induced Gene 2 rs7566605 Is a Protective Factor of Hypercholesteremia Susceptible to Mild Cognitive Impairment, Especially to the Executive Function of Patients with Type 2 Diabetes Mellitus." BioMed Research International 2020 (June 10, 2020): 1–7. http://dx.doi.org/10.1155/2020/4935831.
Texte intégralAl-Zarrad, D., K. Yeung, N. Arebi, L. Dyall, and N. Kamperidis. "P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)." Journal of Crohn's and Colitis 18, Supplement_1 (2024): i1350. http://dx.doi.org/10.1093/ecco-jcc/jjad212.0848.
Texte intégralJha, Niharika, and Vanya Narayan. "Multiple giant tuberous xanthomas with type IIa hypercholesteremia in a young male." Indian Journal of Dermatopathology and Diagnostic Dermatology 7, no. 1 (2020): 38. http://dx.doi.org/10.4103/ijdpdd.ijdpdd_40_20.
Texte intégralMiyayama, Takeshi, Shin-ichiro Miura, Tomo Komaki, et al. "Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia." Journal of Clinical Medicine Research 8, no. 7 (2016): 562–65. http://dx.doi.org/10.14740/jocmr2596w.
Texte intégralYakimenko, O., and Ie Maznichenko. "COMPLEX HYPOLIPIDEMIC THERAPY OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND FAMILIAL HYPERCHOLESTEREMIA." Bulletin of Problems Biology and Medicine 1, no. 2 (2019): 207. http://dx.doi.org/10.29254/2077-4214-2019-1-2-149-207-211.
Texte intégralHyvärinen, Lea. "FLUORESCENCE CINEANGIOGRAPHIC AND HISTOLOGICAL STUDIES ON THE RABBIT EYE DURING EXPERIMENTAL HYPERCHOLESTEREMIA." Acta Ophthalmologica 46, no. 1 (2009): 57–70. http://dx.doi.org/10.1111/j.1755-3768.1968.tb02495.x.
Texte intégralHarper, Claudia, Radhika Seimon, Brendon Yee, Amanda Sainsbury, and Elizabeth Cayanan. "Translating Evidence into Practice: A Case Study of Extended Use of a Very Low Energy Diet for Treatment of Co-Morbid Obesity and Chronic Disease." Recent Progress in Nutrition 2, no. 2 (2022): 1. http://dx.doi.org/10.21926/rpn.2202015.
Texte intégralBarrios, Vivencio, and Carlos Escobar. "Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk." Expert Review of Clinical Pharmacology 14, no. 7 (2021): 793–806. http://dx.doi.org/10.1080/17512433.2021.1925539.
Texte intégralGodal, H. C., J. C. Lund, and E. Sivertssen. "LIPIDS AND LIPOPROTEINS IN SERUM IN CASES OF FAMILIAL ESSENTIAL HYPERCHOLESTEREMIA AND XANTHOMATOSIS." Acta Medica Scandinavica 156, S319 (2009): 125–34. http://dx.doi.org/10.1111/j.0954-6820.1956.tb06306.x.
Texte intégralPereira, Edmundo Luís Rodrigues, Guilherme Alves da Silva, Marília da Silva Duarte, et al. "Systematic review on the relationship between HIV, Antiretroviral Therapy (ART), hyperglycemia and hypercholesteremia." International Journal of Advanced Engineering Research and Science 12, no. 4 (2025): 41–43. https://doi.org/10.22161/ijaers.124.5.
Texte intégralLi, Zhi-Zhao, Qiong Huang, Xiao-li Yang, et al. "Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia." Disease Markers 2022 (April 21, 2022): 1–9. http://dx.doi.org/10.1155/2022/2008556.
Texte intégralRANA, MOHAMMAD MOHSIN, BADAR BASHIR, MUHAMMAD SAEED AKHTAR, and Abaid Ur-Rehman. "TYPE 2 DIABETICS." Professional Medical Journal 14, no. 02 (2007): 337–43. http://dx.doi.org/10.29309/tpmj/2007.14.02.4900.
Texte intégralTermos S, Alrashidi M, Alrushaidan S, et al. "Strawberry Gallbladder: A Distinctive Type of Cholesterolosis, Case Report and Literature Review." Annals of Medical and Clinical Case Reports 01, no. 01 (2024): 01–05. http://dx.doi.org/10.70374/amccr.2024.1102.
Texte intégralYuefeng, Yu, Lin Zhiqi, Chen Yi, et al. "Testosterone Deficiency Promotes Hypercholesteremia and Attenuates Cholesterol Liver Uptake via AR/PCSK9/LDLR Pathways." International Journal of Endocrinology 2022 (May 13, 2022): 1–10. http://dx.doi.org/10.1155/2022/7989751.
Texte intégralAl-Baldawi, Z., L. Brown, I. Ruel, et al. "SEX DIFFERENCES IN THE PRESENTATION, TREATMENT AND OUTCOMES OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEREMIA." Canadian Journal of Cardiology 39, no. 10 (2023): S232. http://dx.doi.org/10.1016/j.cjca.2023.06.355.
Texte intégralAl-Baldawi, Z., L. Brown, I. Ruel, et al. "SEX DIFFERENCES IN THE PRESENTATION, TREATMENT AND OUTCOMES OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEREMIA." Canadian Journal of Diabetes 47, no. 7 (2023): S193. http://dx.doi.org/10.1016/j.jcjd.2023.10.358.
Texte intégralDrew-Nord, Dana C., OiSaeng Hong, Erika S. Froelicher, Phyllis Berryman, and Eileen Lukes. "Cardiovascular Risk Factors among Career Firefighters." AAOHN Journal 57, no. 10 (2009): 415–24. http://dx.doi.org/10.1177/216507990905701004.
Texte intégralMteto Qhayiya, Fihla. "Raising awareness of cardiovascular diseases: A silent killer in South Africa." Journal of Cardiovascular Medicine and Cardiology 11, no. 1 (2024): 013–17. http://dx.doi.org/10.17352/2455-2976.000203.
Texte intégralProute, Matthew, Tiffany Haynes, Robert Fishberg, and Nosagie Ohonba. "Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy." Journal of Clinical Lipidology 18, no. 4 (2024): e543. http://dx.doi.org/10.1016/j.jacl.2024.04.072.
Texte intégral